ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
11 May 2021

Announcement from Acarix’s annual general meeting

Announcement from Acarix's annual general meeting The annual general meeting 2021 ("AGM") of Acarix AB ("Acarix�...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2021

Kommuniké från årsstämman i Acarix

Kommuniké från årsstämman i Acarix Årsstämman 2021 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 11 maj 20...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Apr 2021

Acarix publishes the annual report for 2020

         Press releaseMalmö, Sweden, April 20, 2021 Acarix publishes the annual report for 2020 Today, Tuesday April 20, Acarix is p...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Apr 2021

Acarix publicerar årsredovisningen för 2020

PressmeddelandeMalmö, 20 april 2021 Acarix publicerar årsredovisningen för 2020 Idag, tisdagen den 20 april, publicerar Acarix sin år...
Continue reading
author-avatar acarix
Press
August 6, 2024
12 Apr 2021

Kallelse till årsstämma i Acarix AB

Kallelse till årsstämma i Acarix AB Aktieägarna i Acarix AB, org. nr 559009-0667, ("Bolaget") kallas härmed till årsstämma t...
Continue reading
author-avatar acarix
Press
August 6, 2024
12 Apr 2021

Notice of Annual General Meeting in Acarix AB

  Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are h...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Apr 2021

Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health

            Press releaseMalmö, Sweden, April 7, 2021 Positive, long term prognostic data from the Dan-NICAD I study published in Eur...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Apr 2021

Positiva prognostiska långtidsdata från Dan-NICAD 1-studien publiceras i European Heart Journal Digital Health

Pressmeddelande Malmö, 7 april 2021 Positiva prognostiska långtidsdata från Dan-NICAD 1-studien publiceras i European Heart Journal D...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Feb 2021

Acarix AB (publ) publicerar Bokslutskommuniké 2020

Press release (MAR) Malmö, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommuniké 2020 Ett starkt avslut på ett händelserik...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Feb 2021

A strong ending of an eventful year

Press release (MAR) Malmö, February 18, 2021 Acarix AB (publ) publishes Year-End Report 2020 A strong ending of an eventful year Th...
Continue reading
author-avatar acarix
Press
August 6, 2024
13 Jan 2021

Positive preliminary data from Acarix’s exploratory heart failure study SEISMO

                                                                                                         Press release Malmö, Sweden,...
Continue reading
author-avatar acarix
Press
August 6, 2024
13 Jan 2021

Positiva preliminära data från Acarixs undersökande hjärtsviktstudie SEISMO

                                                                                                         Pressmeddelande Malmö, 13 ja...
Continue reading
  • «
  • ‹
  • 21
  • 22
  • 23
  • 24
  • 25
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.